{{cart_num}}
My CartCAS：33089-61-1
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to yellow Solid
Qty：
Size：
| CAS | 33089-61-1 |
| Name | Amitraz |
| Molecular Formula | C19H23N3 |
| Molecular Weight | 293.41 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 251-375-4 |
| MDL | MFCD00069396 |
| SMILES | CN(/C=N/C1=CC=C(C)C=C1C)/C=N/C2=CC=C(C)C=C2C |
| InChIKey | QXAITBQSYVNQDR-UHFFFAOYSA-N |
| InChI | InChI=1S/C19H23N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3 |
| PubChem CID | 36324 |
| Target Point | Adrenergic Receptor |
| Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
| Background | Amitraz has alpha-adrenergic agonist activity. |
| Biological Activity | Amitraz (NSC 324552) 是一种α2 肾上腺素能受体激动剂。它是非系统性杀螨剂和杀虫剂。[1-2] |
| In Vitro | Amitraz was not cytotoxic to human luteinized granulosa cells at concentrations of 1，10 or 50 μg/ml for exposures of 2-72 h While the highest concentration of amitraz tested，100 μg/ml，caused significant cell death after exposures of 24，48 and 72 h. Amitraz decreased the amount of progesterone produced by each cell after a 4 h exposure; the reduction in progesterone concentration was not caused by decreased cell viability[1]. |
| In Vivo | Amitraz is an α2-adrenergic receptor(α2-AR)agonist that adversely affects the mammalian reproductive system by binding to presynaptic α2-AR in the hypothalamus，thus inhibiting noradrenalin release and decreasing GnRH secretion. When 30 mg/kg of amitraz was administered to rats，the ovulatory LH surge was prevented. Amitraz inhibited insulin but stimulated glucagon secretion in a perfused rat pancreas model. Amitraz also decreased intestinal motility，and inhibited prostaglandin synthesis by bovine seminal vesicle microsomes. Amitraz can be absorbed through the skin and can exert systemic effects via the vascular system in humans[1]. Low doses of AMZ(l-25 mg/kg)decreased motor activity and altered the rates and patterns of responding under schedule-controlled conditions. Intermediate doses(50-100 mg/kg)affect visual-evoked potentials and lower body weight and temperature. In addition，100 mg/kg produces slight MAO inhibition and characteristic signs of intoxication(e.g.，weight loss and hyperreactivity). High doses(>lOO mg/kg)produce more pronounced MAO inhibition，extreme weight loss and hyperreactivity，aggression，and lethality[2]. |
| Data Literature Source | [1] Young FM，et al. Hum Reprod. 2005，20(11):3018-25. [2] Moser VC，et al. Fundam Appl Toxicol. 1989，12(1):12-22. |
| Unit | Bottle |
| Specification | 25mg 50mg 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Manual Download
